Sagimet Biosciences Inc. Phase 1 clinical trial to evaluate the PK of a combination of denifanstat and resmetirom ongoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback